UMB Bank’s Meridian Bioscience Inc VIVO Stock Holding History

UMB Bank’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$33K	–	1812
2022 Q4	$33K	Hold	1,000	–	–	﹤0.01%	965
2022 Q3	$32K	Hold	1,000	–	–	﹤0.01%	978
2022 Q2	$30K	Hold	1,000	–	–	﹤0.01%	1050
2022 Q1	$26K	Hold	1,000	–	–	﹤0.01%	1171
2021 Q4	$20K	Buy	+1,000	New	+$19.2K	﹤0.01%	1280

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UMB Bank's VIVO Position: Q1 2023 in Review

UMB Bank sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 1,000 shares — an estimated $33K sold.

UMB Bank first reported a position in VIVO in Q4 2021 and held it in 5 quarters. The position peaked at $33K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

UMB Bank reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
UMB Bank sold 1,000 Meridian Bioscience Inc shares in Q1 2023, an estimated $33K.
UMB Bank first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 5 quarters.
UMB Bank's Meridian Bioscience Inc position peaked at $33K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on UMB Bank's 13F filing for Q1 2023, filed 11 Apr 2023.